Injectable Bioactive Composite vs Hall Technique for Proximal Cavities in Primary Molars

Starting soon · Not applicable

Conditions studied: Dental Caries

In brief

This randomized clinical trial compares the survival rate and clinical performance of injectable bioactive giomer composite restorations versus the Hall Technique for managing proximal carious lesions (ICDAS 3-4) in primary molars of children aged 3-8 years over a 12-month follow-up period.

Key facts

Study ID

NCT07552129

Run by

Cairo University

People needed

50

Starts

2026-04-01

Expected to finish

2027-07-01

Last updated by the study team

2026-04-27

Who can join

Age: 3 and older, up to 8. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• • Generally showing cooperative behaviour that could be managed by the operators.
• Willing to sign the informed consent.
• Accepts the follow-up period.
• Moderate to low caries risk according to cariogram application
• Posterior primary molar with proximal carious lesion with no sign and symptoms of pulpal involvement.
• Radiographically (bitewing radiograph) extending to the outer1/3 of dentin
• ICDAS (3) and ICDAS(4).

You may not qualify if…

• • Allergy to any restorative materials.
• Patients undergoing orthodontic treatment with fixed appliances.
• Patients with debilitating systemic diseases.
• Children with special needs.
• Teeth with previous restorations.
• Periapical radiolucencies and sensitivity to axial or lateral percussion.
• Mobile teeth.
• External or internal resorption.
• Cervical carious lesions.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.